Simplified and highly-reliable automated production of [

Automation PET Radiopharmaceutical [18F]FSPG

Journal

EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628

Informations de publication

Date de publication:
24 Jul 2023
Historique:
received: 13 06 2023
accepted: 13 07 2023
medline: 24 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

(S)-4-(3- Starting with activity levels of 60-85 GBq, the fully-automated process to produce [ In summary, cGMP-compliant radiosyntheses and quality control of [

Sections du résumé

BACKGROUND BACKGROUND
(S)-4-(3-
RESULTS RESULTS
Starting with activity levels of 60-85 GBq, the fully-automated process to produce [
CONCLUSIONS CONCLUSIONS
In summary, cGMP-compliant radiosyntheses and quality control of [

Identifiants

pubmed: 37486582
doi: 10.1186/s41181-023-00200-8
pii: 10.1186/s41181-023-00200-8
pmc: PMC10366059
doi:

Types de publication

Journal Article

Langues

eng

Pagination

15

Subventions

Organisme : NCI NIH HHS
ID : P50 CA236733
Pays : United States
Organisme : NCI NIH HHS
ID : P50CA236733
Pays : United States
Organisme : NCI NIH HHS
ID : U24CA220325
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA239694
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. The Author(s).

Références

Cell Res. 2020 Feb;30(2):146-162
pubmed: 31949285
Mol Imaging Biol. 2021 Dec;23(6):854-864
pubmed: 34013395
J Nucl Med. 2013 Jun;54(6):861-6
pubmed: 23568366
Cancer Discov. 2020 Aug;10(8):1103-1120
pubmed: 32690542
Br J Cancer. 2008 Aug 5;99(3):464-72
pubmed: 18648370
Clin Cancer Res. 2011 Sep 15;17(18):6000-11
pubmed: 21750203
Clin Nucl Med. 2018 Jan;43(1):28-30
pubmed: 29076915
Mol Imaging Biol. 2023 Jun;25(3):586-595
pubmed: 36525163
J Cancer. 2022 Jan 1;13(1):88-101
pubmed: 34976173
Mol Imaging Biol. 2016 Dec;18(6):924-934
pubmed: 27677886
Antioxid Redox Signal. 2013 Feb 10;18(5):522-55
pubmed: 22667998
Clin Cancer Res. 2012 Oct 1;18(19):5427-37
pubmed: 22893629
PLoS One. 2022 Mar 16;17(3):e0265427
pubmed: 35294486
Cancer Commun (Lond). 2018 Apr 25;38(1):12
pubmed: 29764521
Radiology. 2022 Jun;303(3):620-631
pubmed: 35191738
Nat Cell Biol. 2018 Oct;20(10):1181-1192
pubmed: 30202049
Radiology. 2016 Jun;279(3):898-905
pubmed: 26785040
Cancer Res. 2019 Feb 15;79(4):853-863
pubmed: 30401715
PLoS One. 2016 Feb 18;11(2):e0148628
pubmed: 26890637
EJNMMI Res. 2020 Aug 28;10(1):100
pubmed: 32857284
Cancer Res. 2021 Jun 1;81(11):2807-2814
pubmed: 33446574
PLoS One. 2020 Dec 14;15(12):e0243831
pubmed: 33315962
Pathology. 2013 Feb;45(2):116-26
pubmed: 23277170
Cancers (Basel). 2019 May 16;11(5):
pubmed: 31100816

Auteurs

Mai Lin (M)

Cyclotron Radiochemistry Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.

Robert T Ta (RT)

Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

H Charles Manning (HC)

Cyclotron Radiochemistry Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. HCManning@mdanderson.org.
Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. HCManning@mdanderson.org.

Classifications MeSH